|
Name |
Trichosetin
|
| Molecular Formula | C21H28NO4- | |
| IUPAC Name* |
(Z)-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(E)-prop-1-enyl]-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-[(5S)-5-(hydroxymethyl)-2,4-dioxopyrrolidin-3-ylidene]methanolate
|
|
| SMILES |
C/C=C/[C@@H]1C=C[C@@H]2C[C@@H](CC[C@H]2[C@]1(C)/C(=C/3\C(=O)[C@@H](NC3=O)CO)/[O-])C
|
|
| InChI |
InChI=1S/C21H29NO4/c1-4-5-14-8-7-13-10-12(2)6-9-15(13)21(14,3)19(25)17-18(24)16(11-23)22-20(17)26/h4-5,7-8,12-16,23,25H,6,9-11H2,1-3H3,(H,22,26)/p-1/b5-4+,19-17-/t12-,13-,14-,15-,16+,21-/m1/s1
|
|
| InChIKey |
TYCWBBBQIATAJE-GEZPOGBYSA-M
|
|
| Synonyms |
trichosetin; trichosetin(1-); CHEBI:142061
|
|
| CAS | NA | |
| PubChem CID | 134814698 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 358.5 | ALogp: | 4.6 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 89.5 | Aromatic Rings: | 3 |
| Heavy Atoms: | 26 | QED Weighted: | 0.349 |
| Caco-2 Permeability: | -5.109 | MDCK Permeability: | 0.00000578 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.013 |
| Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.109 |
| 30% Bioavailability (F30%): | 0.007 |
| Blood-Brain-Barrier Penetration (BBB): | 0.117 | Plasma Protein Binding (PPB): | 100.30% |
| Volume Distribution (VD): | 1.44 | Fu: | 3.17% |
| CYP1A2-inhibitor: | 0.699 | CYP1A2-substrate: | 0.652 |
| CYP2C19-inhibitor: | 0.277 | CYP2C19-substrate: | 0.195 |
| CYP2C9-inhibitor: | 0.796 | CYP2C9-substrate: | 0.904 |
| CYP2D6-inhibitor: | 0.868 | CYP2D6-substrate: | 0.214 |
| CYP3A4-inhibitor: | 0.817 | CYP3A4-substrate: | 0.239 |
| Clearance (CL): | 3.551 | Half-life (T1/2): | 0.825 |
| hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.141 |
| Drug-inuced Liver Injury (DILI): | 0.892 | AMES Toxicity: | 0.021 |
| Rat Oral Acute Toxicity: | 0.287 | Maximum Recommended Daily Dose: | 0.363 |
| Skin Sensitization: | 0.287 | Carcinogencity: | 0.023 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.016 |
| Respiratory Toxicity: | 0.933 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004028 | ![]() |
0.636 | D0I5DS | ![]() |
0.252 | ||
| ENC003630 | ![]() |
0.579 | D08PIQ | ![]() |
0.241 | ||
| ENC003021 | ![]() |
0.490 | D0CZ1Q | ![]() |
0.241 | ||
| ENC002818 | ![]() |
0.434 | D04SFH | ![]() |
0.241 | ||
| ENC005182 | ![]() |
0.433 | D06AEO | ![]() |
0.235 | ||
| ENC005181 | ![]() |
0.433 | D0D2TN | ![]() |
0.231 | ||
| ENC003132 | ![]() |
0.400 | D0C8HR | ![]() |
0.230 | ||
| ENC003745 | ![]() |
0.389 | D0F1UL | ![]() |
0.227 | ||
| ENC003689 | ![]() |
0.358 | D0IT2G | ![]() |
0.227 | ||
| ENC002817 | ![]() |
0.357 | D0F1EX | ![]() |
0.227 | ||